GlaxoSmithKline S.A.E (EGX:BIOC)

Market Cap	5.69B
Revenue (ttm)	3.52B
Net Income (ttm)	146.49M
Shares Out	83.51M
EPS (ttm)	1.75
PE Ratio	38.88
Forward PE	n/a
Dividend	0.75 (1.10%)
Ex-Dividend Date	n/a

Volume	939,950
Average Volume	262,808
Open	56.82
Previous Close	56.82
Day's Range	57.58 - 68.18
52-Week Range	30.60 - 68.18
Beta	0.89
RSI	68.55
Earnings Date	Aug 14, 2025

About GlaxoSmithKline S.A.E

GlaxoSmithKline S.A.E. engages in production of pharmaceutical chemicals. The company is involved in manufacture of general and specialty medicines, and vaccines. GlaxoSmithKline S.A.E. was founded in 1981 and is based in London, the United Kingdom. GlaxoSmithKline S.A.E operates as a subsidiary of Glaxo Group Limited.

• Industry: Pharmaceutical Preparations
• Founded: 1981
• Employees: 800
• Stock Exchange: Egyptian Stock Exchange
• Ticker Symbol: BIOC

Financial Performance

In 2024, GlaxoSmithKline S.A.E's revenue was 2.99 billion, an increase of 33.51% compared to the previous year's 2.24 billion. Earnings were 173.98 million, an increase of 187.78%.